Filing Details

Accession Number:
0000899243-21-022987
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-10 17:00:54
Reporting Period:
2021-06-09
Accepted Time:
2021-06-10 17:00:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1703057 Abcellera Biologics Inc. ABCL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1844479 Ester Falconer C/O Abcellera Biologics Inc.
2215 Yukon Street
Vancouver A1 V5Y 0A1
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2021-06-09 1,000,000 $25.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.